Surging Beigene Catches Case of Forex Flu
The drug maker’s net loss grew in the third quarter due to weakness in the Chinese yuan, even as its revenue nearly doubledKey Takeaways:Surging sales for its two self-developed drugs…
Recent Articles
RELATED ARTICLES
Discover hidden China stock gems in our weekly newsletter